Literature DB >> 6517558

Differential stimulation of lymphocyte cell growth in vitro by cephalosporins.

G Leyhausen, G Seibert, A Maidhof, W E Müller.   

Abstract

The in vitro effect of three cephalosporins (cefodizime, cefotaxime, and ceftizoxime) on the growth of the following lymphocytes or their derivatives was tested: L 5178y mouse lymphoma cells, Molt-4 cells, and murine splenic lymphocytes. Within the concentration range of 0.1 to 50 microM, the cephalosporins had no effect on L 5178y cell growth. However, Molt-4 cell growth was significantly stimulated by 0.3 to 20 microM cefotaxime and cefodizime but was not influenced by ceftizoxime. Binding studies with [14C]cefotaxime revealed that the Molt-4 cells responding to the drug bind this cephalosporin to their cell surface (1.9 X 10(5) molecules per cell); no significant binding was observed in the assays with L 5178y cells. Determinations of the extractable activities of DNA-synthesizing enzymes from cefodizime-treated Molt-4 cells showed a direct correlation between cell growth and DNA polymerase alpha as well as terminal deoxynucleotidyl transferase activity; the DNA polymerase beta activity remained unchanged. Cefodizime (0.15 to 50 microM) which was added to mouse spleen cell cultures significantly increased [3H]thymidine incorporation into lymphocytes. This stimulatory effect was less pronounced in concanavalin A-stimulated cultures. These findings suggest that some cephalosporins display a growth-stimulating influence on some lymphocyte populations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6517558      PMCID: PMC180007          DOI: 10.1128/AAC.26.5.752

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  Mammalian DNA polymerases.

Authors:  F J Bollum
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1975

2.  The requirement for L-asparagine of mouse leukemia cells L5178Y in culture.

Authors:  E E HALEY; G A FISCHER; A D WELCH
Journal:  Cancer Res       Date:  1961-05       Impact factor: 12.701

3.  Purification of terminal riboadenylate transferase from calf thymus gland.

Authors:  C M Tsiapalis; J W Dorson; F J Bollum
Journal:  J Biol Chem       Date:  1975-06-25       Impact factor: 5.157

4.  Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases.

Authors:  C Singer; M H Kaplan; D Armstrong
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

5.  Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo.

Authors:  W E Müller; A Maidhof; R K Zahn; W M Shannon
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

6.  Anti-cephalothin antibody and Coombs'-positive hemolytic anemia.

Authors:  R N Rubin; E R Burka
Journal:  Ann Intern Med       Date:  1977-01       Impact factor: 25.391

Review 7.  Eukaryotic DNA polymerases.

Authors:  A Weissbach
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

8.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

9.  Induction of DNA polymerase in mouse L cells.

Authors:  L M Chang; M Brown; F J Bollum
Journal:  J Mol Biol       Date:  1973-02-15       Impact factor: 5.469

10.  Purification and properties of deoxyribonucleic acid polymerase from nuclei of sea urchin embryos.

Authors:  L A Loeb
Journal:  J Biol Chem       Date:  1969-04-10       Impact factor: 5.157

View more
  4 in total

1.  Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro.

Authors:  M T Labro; N Amit; C Babin-Chevaye; J Hakim
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

2.  Cefodizime host-defence enhancement: considerations of dose-response relationships in healthy volunteers.

Authors:  G Gialdroni Grassi; P M Shah
Journal:  Infection       Date:  1992       Impact factor: 3.553

3.  Immunopharmacological activity of cefodizime in young and elderly subjects: in vitro and ex vivo studies.

Authors:  P L Meroni; F Capsoni; M O Borghi; W Barcellini; F Minonzio; A M Ongari; C Fain; C Hu; G Brambilla; C Pettenati
Journal:  Infection       Date:  1992       Impact factor: 3.553

Review 4.  Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  L B Barradell; R N Brogden
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.